Apr 27, 2021 / 08:30PM GMT
Operator
Good afternoon, and welcome to the AtriCure's First Quarter 2021 Earnings Conference Call. My name is Mel, and I will be your coordinator for the call today. (Operator Instructions) As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Lynn Lewis from the Gilmartin Group for a few introductory comments. Ma'am?
Lynn Pieper Lewis - Gilmartin Group LLC - Founder & CEO
Thank you. By now, you should have received a copy of the earnings press release. If you have not received a copy, please call (513) 755-4136 to have one e-mailed to you.
Before we begin today, let me remind you that the company's remarks include forward-looking statements. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond AtriCure's control, including risks and uncertainties described from time to time in AtriCure's SEC filings. These statements include, but are not limited to, financial guidance, expectations regarding the timing of FDA reviews and expectations for product
Q1 2021 AtriCure Inc Earnings Call Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers